Loading...

Genta Incorporated is a biopharmaceutical company focused on the identification, development and commercialization of drugs for the treatment of people with cancer. Genta has built a broad portfolio of proprietary products in various stages of clinical development. The Company’s drugs include Ganite® (gallium nitrate injection), Genasense® (oblimersen sodium) injection, tesetaxel, and oral gallium. Genta is committed to developing innovative products to better the lives of people with cancer.   Learn More

Loading...
home-callout-1-top
Leadership in Cancer Drug Development

Genta's team has extensive drug development and commercialization experience.

Read More
Loading...
home-callout-2
Oncology Focused Pipeline

Genasense® (oblimersen sodium) Injection inhibits the production of a protein known as Bcl-2. 

Read More

Click to view the Bcl-2 Mechanism of Action Video

video-preview-btn

  • August 5, 2010
    Genta Incorporated to Host Conference Call to Discuss Second Quarter 2010 Highlights and Financial Results
    Read More
  • June 11, 2010
    Genta Incorporated Announces Webcast of 2010 Annual Shareholders Meeting
    Read More
  • June 7, 2010
    Tesetaxel Results from Two Clinical Dose-Ranging Trials Presented at ASCO
    Read More
  •  2010 Annual Shareholders Meeting

    2010-06-15
    Morristown, NJ
  • 2’Q 2010 Earnings Teleconference

    2010-08-12
    Berkeley Heights, NJ
  •  20th German Skin Cancer Conference

    2010-09-23
    Kiel, Germany